Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Lysocardiolipin Acyltransferase 1 (LCLAT1) Peptide

LCLAT1 Reactivity: Mammalian Host: Synthetic BP, WB, IHC
Catalog No. ABIN936156
  • Target See all LCLAT1 products
    LCLAT1 (Lysocardiolipin Acyltransferase 1 (LCLAT1))
    Peptide Type
    Synthetic
    Origin
    Mammalian
    Source
    • 1
    Synthetic
    Application
    Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
    Sequence
    YLYSLVKWYF IITIVIFVLQ ERIFGGLEII ELACYRLLHK QPHLNSKKNE
    Characteristics
    A synthetic peptide for use as a blocking control in assays to test for specificity of LYCAT antibody,
    Alternative Names: LYCAT control peptide, LYCAT antibody Blocking Peptide, Anti-LYCAT Blocking Peptide, Lysocardiolipin Acyltransferase Blocking Peptide, ALCAT1 Blocking Peptide, FLJ37965 Blocking Peptide, UNQ1849 Blocking Peptide
  • Application Notes
    Optimal conditions should be determined by the investigator
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
    Buffer
    PBS
    Handling Advice
    Avoid repeated freeze/thaw cycles.
    Storage
    -20 °C
    Storage Comment
    Store at -20 °C long term.
  • Target
    LCLAT1 (Lysocardiolipin Acyltransferase 1 (LCLAT1))
    Synonyms
    lclat1 Peptide, zgc:77380 Peptide, wu:fj17g04 Peptide, LYCAT Peptide, lycat Peptide, agpat8 Peptide, alcat1 Peptide, 1agpat8 Peptide, AGPATP8 Peptide, 1AGPAT8 Peptide, AGPAT8 Peptide, ALCAT1 Peptide, HSRG1849 Peptide, UNQ1849 Peptide, AI181996 Peptide, Agpat8 Peptide, Alcat1 Peptide, Gm91 Peptide, Lycat Peptide, RGD1565906 Peptide, lysocardiolipin acyltransferase 1 Peptide, lclat1 Peptide, LCLAT1 Peptide, Lclat1 Peptide
    Background
    LYCAT is an acyl-CoA:lysocardiolipin acyltransferase. It possesses both lysophosphatidylinositol acyltransferase (LPIAT) and lysophosphatidylglycerol acyltransferase (LPGAT) activities. LYCAT recognises both monolysocardiolipin and dilysocardiolipin as substrates with a preference for linoleoyl-CoA and oleoyl-CoA as acyl donors. LYCAT acts as a remodeling enzyme for cardiolipin, a major membrane polyglycerophospholipid. It converts lysophosphatidic acid (LPA) into phosphatidic acid (PA) with a relatively low activity. LYCAT is required for establishment of the hematopoietic and endothelial lineages.
    Molecular Weight
    44 kDa
You are here:
Support